It's getting a bit repetitive. The call (battle cry) for repeal, waivers or at least a delay in health reform is everywhere in the health insurance industry. It's also coming from retailers, pharmacies and manufacturers.

Last week, opposition resonated from a number of groups that want Congress to change the new federal law, effective Jan. 1, and allow over-the-counter drugs to be purchased with money from flexible spending accounts.

These groups are asking Congress — during its lame duck session — to push back the law's start date two years, if it won't repeal altogether.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.